The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A single-arm, phase II study of durvalumab (D) and tremelimumab (T) for relapsed/refractory germ cell tumors (GCT).
 
Samuel A Funt
Employment - ByHeart (I)
Stock and Other Ownership Interests - 76Bio (I); Allogene Therapeutics; Doximity; IconOVir Bio (I); Kite, a Gilead company; Kronos Bio; Neogene Therapeutics (I); Urogen pharma (I); Vida Ventures (I)
Consulting or Advisory Role - BioNtech; Immunai; Merck
Research Funding - AstraZeneca (Inst); Decibel Therapeutics (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Andrea Knezevic
Consulting or Advisory Role - ByHeart
 
Benjamin A Freeman
No Relationships to Disclose
 
Mary Bolos
No Relationships to Disclose
 
Victoria Martorana
No Relationships to Disclose
 
Mark Donoghue
No Relationships to Disclose
 
Shah Khan
No Relationships to Disclose
 
Harleen Singh
No Relationships to Disclose
 
Maria Bromberg
No Relationships to Disclose
 
Colleen Quinlan
No Relationships to Disclose
 
Maryann Carousso
No Relationships to Disclose
 
Achim A. Jungbluth
Patents, Royalties, Other Intellectual Property - I receive royalties and own IP for several monoclonal antibodies developed during my time at the Ludwig Institute for Cancer Research (LICR) and MSKCC. I receive royalties from LICR and MSKCC, not from any company!
 
Sujata Patil
Consulting or Advisory Role - ByHeart
 
Neil J. Shah
Honoraria - MedNet, LLC; MedNet, LLC; MJH Life Sciences
Consulting or Advisory Role - Exelixis; Graticule; Merck Sharp & Dohme Corp.
Research Funding - Aravive (Inst); Exelixis
Travel, Accommodations, Expenses - Merck
 
Chung-Han Lee
Honoraria - American Institute of Continuing Medical Education; Ideology Health; Intellisphere; Medscape; Research to Practice
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; Cardinal Health; Eisai; Eisai; Exelixis; Merck; Pfizer/EMD Serono
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Eisai (Inst); Exelixis (Inst); Merck (Inst)
 
Deaglan Joseph McHugh
Honoraria - OncLive
Consulting or Advisory Role - Progenics
 
Hikmat A. Al-Ahmadie
Consulting or Advisory Role - AstraZeneca/MedImmune; Janssen Biotech; PAIGE.AI
 
Darren R. Feldman
Consulting or Advisory Role - BioNTech; Cigna
Research Funding - Astellas Pharma; Decibel Therapeutics (Inst); Telix Pharmaceuticals
Other Relationship - UpToDate